TCM Daoyin: The TCM Daoyin training program consisted of two 90-min training classes and at least five 30-min at-home practice sessions per week for 16-weeks. All sessions included 10 min of warmup and 10 min of cooldown.
Health education: Health education is provided by doctor and nurse, including work, rest, diet and other basic programs.
Study summary
Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease. The aim of prospective randomized study is to evaluate the effects of TCM Daoyin training on Individuals at-risk for COPD.
Eligibility
Sex
ALL
Min age
40 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Subject at-risk for COPD (Chronic obstructive pulmonary disease screening questionnaire (COPD-SQ) score≥16; and pre-bronchodilator FEV1/FVC ≥ 0.70, or pre-bronchodilator FEV1/FVC\<0.70 but post-bronchodilator FEV1/FVC ≥ 0.70).
* Aged 40 to 75, male or female.
* Subject has a clear mind and the ability to lead an independent life.
* Subject agrees to perform a blood-test.
* Subject agrees to participate in this study and sign to the informed consent.
Exclusion Criteria:
* Subject with acute exacerbation of COPD.
* Subject with respiratory infectious disease (e.g., tuberculosis, influenza, etc.) within 1 month.
* Subject with serious current unstable physical illness and mental illness.
* Subject with definite clinical diagnosis of Alzheimer's disease, or severe cognitive impairment.
* Subject is pregnant or lactating women.
Primary outcome measure(s)
Lung function — Change from Baseline lung function at 16 weeks Participants' lung function (FVC、FVC%、FEV1、FEV1%、FEV1/FVC) will be tested to identify air flow condition in both group.
Trial sites (2)
Facility
City
Region
Status
Shanghai Qigong Research Institute
Shanghai
Shanghai Municipality
Changzheng Community Health Service Center of Putuo District, Shanghai
Shanghai
Shanghai Municipality
More Shanghai University of Traditional Chinese Medicine trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.